You are here
GLEN ALLEN, Va. – Smokeless tobacco company Star Scientific Inc. filed an application with the Food and Drug Administration (FDA) for approval to market a new smokeless tobacco item as a modified-risk tobacco product, under regulations by the Family Smoking Prevention and Tobacco Control Act of 2009, the Winston-Salem Journal reported.
The new product, under the name Stonewall-BDLT, is the company's second application of its type to the Tobacco Products Center of the FDA, according to the report. The first, for ARIVA-BDLT, was filed by Star Feb. 19. The company stated that it believes these are the only applications for modified-risk products that have been filed with the FDA to date.
Stonewall-BDLT, like ARIVA-BDLT, is a dissolvable tobacco lozenge with wintergreen flavoring, the Journal reported. The product is made with flue-cured tobacco containing levels of tobacco-specific nitrosamines that are below detectable limits by most current standards of measure, the report stated.
Marlboro Light Package Onserts Get FDA Attention
Details of New Tobacco Retailing Rules Under FDA